Zai Lab (ZLAB) Non-Current Assets (2016 - 2026)
Zai Lab's (ZLAB) quarterly Non-Current Assets came in at $151.0 million in Q1 2026, up 14.87% year-on-year from $131.5 million in Q1 2025, and down 1.37% quarter-over-quarter from $153.1 million in Q4 2025.
Zai Lab (ZLAB) Non-Current Assets (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Non-Current Assets across 11 years of filings, most recently posting $151.0 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $151.0 million, up 14.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $560.1 million (up 10.05% YoY), and the FY2025 annual result was $153.1 million, up 13.18% from the prior year.
- Non-Current Assets came in at $151.0 million for Q1 2026 at Zai Lab, down from $153.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $153.1 million in Q4 2025 to a low of $83.1 million in Q2 2022.
- The 5-year median for Non-Current Assets is $107.7 million (2022), against an average of $112.4 million.
- Across the five-year window, Non-Current Assets fell 18.63% in 2022 and surged 48.63% in 2024, its largest moves.
- Zai Lab's Non-Current Assets stood at $95.8 million in 2022, then increased by 0.92% to $96.7 million in 2023, then soared by 39.91% to $135.3 million in 2024, then climbed by 13.18% to $153.1 million in 2025, then decreased by 1.37% to $151.0 million in 2026.
- The last three Non-Current Assets figures came in at $151.0 million (Q1 2026), $153.1 million (Q4 2025), and $126.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 151.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.01 Mn |
| Dec 31, 2025 | 153.10 Mn |
| Sep 30, 2025 | 125.99 Mn |
| Jun 30, 2025 | 130.04 Mn |
| Mar 31, 2025 | 131.46 Mn |
| Dec 31, 2024 | 135.27 Mn |
| Sep 30, 2024 | 124.80 Mn |
| Jun 30, 2024 | 117.45 Mn |
| Mar 31, 2024 | 99.80 Mn |
| Dec 31, 2023 | 96.69 Mn |
| Sep 30, 2023 | 83.96 Mn |
| Jun 30, 2023 | 88.87 Mn |
| Mar 31, 2023 | 97.78 Mn |
| Dec 31, 2022 | 95.80 Mn |
| Sep 30, 2022 | 88.68 Mn |
| Jun 30, 2022 | 83.13 Mn |
| Mar 31, 2022 | 107.66 Mn |
| Dec 31, 2021 | 109.08 Mn |
| Sep 30, 2021 | 108.99 Mn |
| Jun 30, 2021 | 86.61 Mn |